UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 22, 2008

THE COOPER COMPANIES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware		1-8597		94-2657368
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

6140 Stoneridge Mall Road, Suite 590, Pleasanton, California 94588

(Address of principal executive offices)

(925) 460-3600

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

---

ITEM 8.01.

Other Events.

On February 22, 2008, the Company issued a press release to announce the appointment of John A. Weber to the position of President of CooperVision, Inc., the Company’s contact lens subsidiary. A copy of the press release is filed as Exhibit 99.1 to this Current Report and incorporated by reference herein.

Internet addresses in the release are for information purposes only and are not intended to be hyperlinks to other Company information.

 

ITEM 9.01.

Financial Statements and Exhibits.

 

(d)

Exhibits.

 

Exhibit No.		Description
99.1		Press release dated February 22, 2008

 

2

---

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: February 22, 2008

 

3

---

EXHIBIT INDEX

 

Exhibit No.		Description
99.1		Press release dated February 22, 2008

 

4

Exhibit 99.1

 

NEWS RELEASE

 

CONTACT:   Albert G. White, III The Cooper Companies, Inc. ir@coopercompanies.com		6140 Stoneridge Mall Road Suite 590 Pleasanton, CA 94588 925-460-3663 www.coopercos.com

FOR IMMEDIATE RELEASE

COOPER APPOINTS WEBER PRESIDENT OF COOPERVISION

PLEASANTON, Calif., February 22, 2008 — The Cooper Companies, Inc. (NYSE: COO) today announced that John A. Weber has been appointed president of CooperVision. Weber previously served as president, Asia Pacific since April 2007 and vice president, worldwide manufacturing and distribution of CooperVision from January 2005 to March 2007. Prior to that, he served in several senior executive positions at Ocular Sciences, Inc. including executive vice president, worldwide operations.

Commenting on the appointment, Robert S. Weiss, Cooper’s chief executive officer, said, “John brings extensive worldwide operational experience to his new role. With his background and experience within CooperVision, he is ideally suited to continue driving our success.”

The Cooper Companies, Inc. (www.coopercos.com) manufactures and markets specialty healthcare products through its CooperVision and CooperSurgical units. Corporate offices are in Pleasanton, Calif.

CooperVision (www.coopervision.com) develops, manufactures and markets a broad range of contact lenses for the worldwide vision correction market. Headquartered in Pleasanton, Calif., it manufactures in Juana Diaz, Puerto Rico, Norfolk, Va., Rochester, N.Y., Adelaide, Australia, Hamble and Hampshire, England and Madrid, Spain.

CooperSurgical (www.coopersurgical.com) develops, manufactures and markets medical devices, diagnostic products and surgical instruments and accessories used primarily by gynecologists and obstetricians. Its major manufacturing and distribution facilities are in Trumbull, Conn.

###

 

1